Ostrowski Erik — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Ostrowski Erik has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $262K.

Profile

Ostrowski Erik

Erik Ostrowski is a corporate executive known for his roles at Akebia Therapeutics, Inc., where he serves as Senior Vice President, Chief Financial Officer, Chief Business Officer, and Treasurer. He has been involved in the biopharmaceutical sector, particularly focusing on developing therapeutics for kidney disease.

RoleInsider
Notability20/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-01AKBAAkebia Therapeutics, Inc.S — Open-market sale56.0K$1.11$62K
2026-02-04AKBAAkebia Therapeutics, Inc.S — Open-market sale [10b5-1]35.0K$1.39$49K
2026-02-03AKBAAkebia Therapeutics, Inc.A — Grant or award204.0K$0.00
2025-06-30AKBAAkebia Therapeutics, Inc.S — Open-market sale41.3K$3.67$152K

Companies — Last 90 Days

Frequently Asked Questions

Who is Ostrowski Erik?

Erik Ostrowski is a corporate executive known for his roles at Akebia Therapeutics, Inc., where he serves as Senior Vice President, Chief Financial Officer, Chief Business Officer, and Treasurer. He has been involved in the biopharmaceutical sector, particularly focusing on developing therapeutics for kidney disease.…

How many SEC Form 4 filings has Ostrowski Erik submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Ostrowski Erik been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($262K) across all tracked filings.

Where can I see all of Ostrowski Erik's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Ostrowski Erik profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.